Disease | hepatitis b |
Symptom | |chronic infection |
Sentences | 209 |
PubMedID- 20085587 | In addition, a possible association between chronic infection with hepatitis b and c viruses and cholangiocarcinoma was also noted. |
PubMedID- 22184515 | The main hepatic complications of multiple transfusions include acute and chronic infection with hepatitis b and c and iron overload. |
PubMedID- 25512154 | Findings: chronic infection with epstein-barr virus, hepatitis b and c viruses, kaposi sarcoma herpes virus, human immunodeficiency virus (hiv) type 1, human papillomavirus (hpv), human t-cell lymphotropic virus type 1, helicobacter pylori, clonorchis sinensis, opisthorchis viverrini, and schistosoma haematobium are associated with nasopharyngeal carcinoma; lymphoma and leukemia, including non-hodgkin lymphoma, hodgkin lymphoma, and burkitt lymphoma; hepatocellular carcinoma; kaposi sarcoma; oropharyngeal carcinoma; cervical carcinoma and carcinoma of other anogential sites; adult t-cell leukemia/lymphoma; gastric carcinoma; cholangiocarcinoma; and urinary bladder cancer. |
PubMedID- 26434859 | chronic infection with the hepatitis b virus is the major factor leading to hcc progression since it causes the liver injury. |
PubMedID- 24373091 | Hepatocellular carcinoma (hcc) is a frequent, long term complication of chronic infection with hepatitis b virus (hbv) with an annual incidence ranging from 2 to 5%, often independent from the histological stage of underlying liver disease and serological status. |
PubMedID- 25884472 | Most cases of hcc are attributed to chronic infection with either hepatitis b or c virus 2. |
PubMedID- 21682827 | Although chronic infection with hepatitis b virus (hbv) and/or hepatitis c virus (hcv) are the most important risk factors for the development of hepatocellular carcinoma (hcc) worldwide, the proportion of hcc patients negative for the hepatitis b surface antigen and hepatitis c antibody, so-called "non-b non-c hcc", is rapidly increasing, especially in japan. |
PubMedID- 23718853 | chronic infection of hepatitis b and c can advances to cirrhosis and hcc. |
PubMedID- 23437062 | chronic infection with hepatitis b virus (hbv) and hepatitis c virus (hcv), alcohol abuse, environmental and occupational toxins, as well as certain metabolic and immune disorders are risk factors of hcc . |
PubMedID- 23593449 | It is well-known to be associated with the chronic infection of hepatitis b (hbv) and hepatitis c (hcv) viruses. |
PubMedID- 24336972 | chronic infection with hepatitis b virus (hbv) is the major risk factor for the development of hcc, while hepatitis b virus x protein (hbx) is essential for hbv-associated hcc. |
PubMedID- 20429960 | chronic infection with hepatitis b virus (hbv) occurs in approximately 6% of the world's population and carriers of the virus are at risk for hepatocellular carcinoma and cirrhosis. |
PubMedID- 26317595 | Background: chronic infection with the hepatitis b virus and obesity may both contribute synergistically to liver disease, although relatively few studies have investigated this hypothesis. |
PubMedID- 24936402 | In his medical history, the existence of a non-insulin dependent diabetes and asymptomatic chronic infection with hepatitis b virus (hbv) were recorded. |
PubMedID- 22190911 | Innate and adaptive immune systems have important role in the pathogenesis of acute and chronic infection with hepatitis b virus (hbv). |
PubMedID- 24376578 | Previous epidemiological studies have identified that major risk factors for the development of hcc are chronic infection with hepatitis b virus (hbv) or hepatitis c virus (hcv), liver cirrhosis, habitual alcohol abuse, and exposure to aflatoxin b1 . |
PubMedID- 23039099 | Epidemiologic and experimental evidence has shown that chronic infection with hepatitis b and c virus (hbv, hcv) is a major risk factor for hepatocellular carcinoma (hcc). |
PubMedID- 24708820 | Morocco is a country of intermediate endemicity for chronic infections with hepatitis b (hbv) and c (hcv) viruses, where a consistently low level of food contamination by aflatoxins b1. |
PubMedID- 21268724 | Background: chronic infection with hepatitis b virus and hepatitis delta virus (hdv) results in the most severe form of viral hepatitis. |
PubMedID- 23400006 | A major risk factor is chronic infection with hepatitis b virus (hbv) or hepatitis c virus (hcv)8. |
PubMedID- 26139985 | chronic infection with the hepatitis b virus (hbv) is the leading risk factor for the development of hepatocellular carcinoma (hcc). |
PubMedID- 20331884 | chronic infections with hepatitis b virus (hbv) and hepatitis c virus (hcv) are a leading cause of hepatocellular carcinoma, a condition whose incidence rate remains high in the developing world and is rising across most developed countries 1. |
PubMedID- 23024757 | Among them, chronic infection with hepatitis b virus (hbv) is one of the major etiological factors for developing hcc with considerable regional variations ranging from 20% of hcc cases in japan to 65% in china 3. |
PubMedID- 22807686 | Major risk factors for hcc are chronic infections with the hepatitis b or c viruses, and exposure to dietary aflatoxin b1. |
PubMedID- 23323209 | The world health organization has estimated that the prevalence of chronic infections with hepatitis b virus (hbv) and hepatitis c virus (hcv) is more than 5% of the world population. |
PubMedID- 25750558 | chronic infection with the hepatitis b virus (hbv) is a major cause of cirrhosis and hepatocellular carcinoma (hcc) worldwide. |
PubMedID- 22230186 | chronic infection with hepatitis b virus (hbv) frequently leads to serious liver disease such as cirrhosis, fulminant hepatic failure, and hepatocellular carcinoma 1. |
PubMedID- 21261993 | chronic infection with hepatitis b virus (hbv) or hepatitis c virus (hcv) is associated with increased morbidity and mortality. |
PubMedID- 21618261 | Background: chronic infection with hepatitis b virus and hepatitis delta virus (hdv) results in the most severe form of viral hepatitis. |
PubMedID- 23433483 | chronic infection with hepatitis b or c viruses and alcohol consumption are considered the most important risk factors for liver cancer. |
PubMedID- 22923916 | chronic infection with hepatitis b virus (hbv) is a global public health problem, often called the ‘silent killer’, which eventually leads to liver cirrhosis, decompensated hepatic disease, or hepatocellular carcinoma in 20-40% of patients. |
PubMedID- 22969921 | Previous epidemiological studies have found that chronic infection with hepatitis b virus (hbv) is one of the major etiological risk factors for hcc in china. |
PubMedID- 20628618 | Hepatocellular carcinoma (hcc) is a primary cancer that originates in hepatocytes and typically follows cirrhosis or chronic-hepatitis virus infections , and the most significant risk factors for hcc are chronic infections with either hepatitis b virus or hepatitis c virus (hcv). |
PubMedID- 22114736 | The highest hcc incidence rates are areas endemic for chronic infection with hepatitis b virus (asia and africa). |
PubMedID- 26453548 | In eastern asian countries, including taiwan, chronic infection with hepatitis b virus (hbv) is the dominant risk factor . |
PubMedID- 22611419 | In chronic infection with hepatitis b virus or hcv, specific ctls are few and engage few specific targets; they also display anergic characteristics with reduced type 1 cytokine secretion . |
PubMedID- 25034398 | Background: chronic infection with hepatitis b virus (hbv) is the major risk factor of hepatocellular carcinoma (hcc). |
PubMedID- 23012649 | They found that adefovir dipivoxil (9-. |
PubMedID- 26102214 | The main risk factor for hcc is chronic infection with hepatitis b or c that may lead to cirrhosis which is present in 80% to 90% of the cases of hcc . |
PubMedID- 24397793 | chronic infection with hepatitis b virus (hbv) is a major cause of death from cirrhosis and liver cancer, chiefly in south-east asia and sub-saharan africa . |
PubMedID- 24914367 | chronic infections with hepatitis b virus (hbv) and/or hepatitis c virus (hcv) are the major causes of cirrhosis globally. |
PubMedID- 24133665 | A chronic infection with hepatitis b virus (hbv) results in substantial morbidity and mortality worldwide, claiming up to 1 million deaths annually.1 chronic hepatitis b (chb) can be a silent disease for decades, but cirrhosis, liver failure, and hepatocellular carcinoma (hcc) can be the result of untreated infection.2,3 lamivudine (lam) is the first nucleoside analog approved for treatment of chb, and has been applied globally for chb patients. |
PubMedID- 20889864 | Chronic viral hepatitis is common among adults in many tropical and sub-tropical countries where dengue is endemic, and it has been postulated that dengue infection occurring on a background of chronic infection with hepatitis b virus (hbv) or hepatitis c virus (hcv) may result in more severe liver dysfunction and/or hemorrhage than is usual in non-infected persons. |
PubMedID- 24379608 | chronic infection with hepatitis b virus (hbv) and hepatitis c virus accounts for approximately 75%-80% of hcc cases worldwide. |
PubMedID- 25338920 | chronic infection with hepatitis b virus (hbv) puts individuals at high risk for complicating cirrhosis and liver cancer, but available treatment to counter the virus rarely eliminates infection. |
PubMedID- 22448225 | Background and aims: chronic infection with the hepatitis b virus (hbv) is a major health issue worldwide. |
PubMedID- 21243800 | Vaccination of the newborns and adolescents had impact on the incidence of acute and chronic infection with hepatitis b virus (hbv) in children. |
PubMedID- 22171899 | chronic infection with hepatitis b virus (hbv) is a major risk factor for hcc, accounting for more than one half of cases worldwide (2). |
PubMedID- 21573166 | Among the well known risk factors for hcc, chronic infection with hepatitis b (hbv) or c (hcv) virus is present in more than 85% of primary liver cancers 1. |
PubMedID- 23188673 | Overwhelmingly, chronic infection with hepatitis b virus (hbv) is recognized important risk factors of hcc in many countries, including china. |